MedPath

Shanghai Renji Hospital,Shanghai Jiaotong University,School of Medicine

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

Phase 2
Conditions
Hepatocellular Carcinoma
Interventions
Drug: Placebo
Drug: Immunosuppressive regimen
First Posted Date
2019-11-19
Last Posted Date
2019-11-19
Lead Sponsor
RenJi Hospital
Target Recruit Count
108
Registration Number
NCT04168944

A Multicenter Randomized Controlled Study of the Effect of Laparoscopic Preservation of the Pylorus

Not Applicable
Not yet recruiting
Conditions
Quality of Life
Interventions
Procedure: lappg
First Posted Date
2019-11-15
Last Posted Date
2019-12-05
Lead Sponsor
RenJi Hospital
Target Recruit Count
160
Registration Number
NCT04164095

A Real World Study of Laparoscopic Preservation of the Pylorus Gastrectomy

Not yet recruiting
Conditions
Gastric Cancer
Interventions
Procedure: lappg
First Posted Date
2019-11-13
Last Posted Date
2019-11-13
Lead Sponsor
RenJi Hospital
Target Recruit Count
160
Registration Number
NCT04160962

Early rhBNP on Myocardial Work in Patients With STEMI

Phase 4
Conditions
ST-Segment Elevated Myocardial Infarction
Interventions
Drug: Control
First Posted Date
2019-11-08
Last Posted Date
2019-11-08
Lead Sponsor
RenJi Hospital
Target Recruit Count
200
Registration Number
NCT04157868

Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients

Not Applicable
Conditions
Polycystic Ovary Syndrome
Severe Obesity
Laparoscopic Sleeve Gastrectomy
Interventions
First Posted Date
2019-11-05
Last Posted Date
2019-11-05
Lead Sponsor
RenJi Hospital
Target Recruit Count
18
Registration Number
NCT04151459
Locations
🇨🇳

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer

Phase 2
Conditions
Gastric Cancer Stage III
Interventions
First Posted Date
2019-11-05
Last Posted Date
2020-04-20
Lead Sponsor
RenJi Hospital
Target Recruit Count
20
Registration Number
NCT04152889
Locations
🇨🇳

Ethics Committee of Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

Metformin In Prevention of Lupus Nephritis

Phase 4
Conditions
Lupus Nephritis
Interventions
First Posted Date
2019-10-31
Last Posted Date
2019-10-31
Lead Sponsor
RenJi Hospital
Target Recruit Count
30
Registration Number
NCT04145687
Locations
🇨🇳

Fangfang Sun, MD, Shanghai, Shanghai, China

Dexmedetomidine and Propofol in the Treatment of Emergence Agitation

Early Phase 1
Conditions
Emergence Agitation
Interventions
First Posted Date
2019-10-29
Last Posted Date
2020-01-14
Lead Sponsor
RenJi Hospital
Target Recruit Count
120
Registration Number
NCT04142840
Locations
🇨🇳

Renji Hospital,Shanghai Jiao Tong University,School of Medicine, Shanghai, Shanghai, China

Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Phase 2
Active, not recruiting
Conditions
Breast Cancer Female
Interventions
First Posted Date
2019-10-15
Last Posted Date
2023-11-21
Lead Sponsor
RenJi Hospital
Target Recruit Count
53
Registration Number
NCT04126525
Locations
🇨🇳

Renji Hospital, Shanghai, China

Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Phase 2
Completed
Conditions
Neoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell Carcinoma
Interventions
First Posted Date
2019-10-08
Last Posted Date
2023-04-04
Lead Sponsor
RenJi Hospital
Target Recruit Count
20
Registration Number
NCT04118855
Locations
🇨🇳

Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath